SCHEMBL1461157

SCHEMBL1461157

Cc1ccccc1-c1nc2ccccc2c(=O)[nH]1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GUSB P08236 8/20 0.68
▸ HPGD P15428 3/20 0.68
▸ KDM4E B2RXH2 1/20 0.68
▸ TNKS2 Q9H2K2 5/20 0.63
▸ PARP1 P09874 4/20 0.63
▸ TNKS O95271 4/20 0.63
▸ NPC1 O15118 2/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ HTT P42858 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ MAPT P10636 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ APOBEC3G Q9HC16 1/20 0.56
▸ PARP2 Q9UGN5 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29784109 1.00 GUSB (0.68) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL29900574 0.89 GUSB (0.62) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL27635892 0.89 GUSB (0.62) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL4080197 0.85 TUBB4A (0.54) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL4085165 0.83 TUBB4A (0.52) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL4080440 0.83 TUBB4A (0.52) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL6695759 0.82 TNKS2 (0.81) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL28135155 0.82 GUSB (0.69) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL2606253 0.81 GUSB (0.68) GUSBHPGDKDM4ETNKS2PARP1
SCHEMBL802560 0.81 GUSB (0.68) GUSBHPGDKDM4ETNKS2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4642309-B2 — — 2011-03-02 — — JP claimed
JP-2003531209-A — — 2003-10-21 — — JP claimed
EP-1278748-A2 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2003-01-29 — — EP claimed
WO-2001081346-A2 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2001-11-01 — — WO claimed
JP-8143586-A — — None — — JP disclosed
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO disclosed
CN-109879820-B Synthetic method of quinazolinone heterocyclic compound 扬州大学 2022-07-19 — — CN disclosed
CN-106518789-B A method of synthesis Quinazol derivative 南京理工大学 2019-04-16 — — CN disclosed
CN-106518789-A Method for synthesis of quinazolinone derivative 南京理工大学 2017-03-22 — — CN disclosed
CN-106478525-A A kind of method of synthesis quinazolone 南京理工大学 2017-03-08 — — CN disclosed
CN-104496915-A Synthetic method of quinazolinone aromatic compound UNIV HUAQIAO 2015-04-08 — — CN disclosed
US-8283354-B2 Voltage gated sodium and calcium channel inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-09 — — US disclosed
WO-2005117889-A1 METHODS FOR TREATING AND/OR PREVENTING ABERRANT PROLIFERATION OF HEMATOPOIETIC ICOS CORPORATION (US) 2005-12-15 — — WO disclosed
EP-1438052-A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA ICOS CORPORATION (US) 2004-07-21 — — EP disclosed
WO-2003035075-A1 INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2003-05-01 — — WO disclosed
EP-0749974-B1 PHOSPHONIC DIESTER DERIVATIVE OTSUKA PHARMA CO LTD (JP) 2001-06-27 — — EP disclosed
US-5798344-A TREATING DIABETES, HYPERLIPIDEMIA OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1998-08-25 — — US disclosed
EP-0749974-A1 PHOSPHONIC DIESTER DERIVATIVE OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1996-12-27 — — EP disclosed
JP-H08143586-A PHOSPHONIC ACID DIESTER DERIVATIVE OTSUKA PHARMACEUT FACTORY INC 1996-06-04 — — JP disclosed
US-3998951-A Substituted 2-arylquinazolines as fungicides FMC CORPORATION (US) 1976-12-21 — — US disclosed
Send feedback